PTGER4 and pancreatic neoplasm: Although the generation of tumor cell debris and inflammation may be an inherent limitation of current cancer therapy, overcoming the dilemma of debris-induced tumor progression with the inhibition of sEH and EP4 represents a promising approach to prevent hepato-pancreatic tumor growth, metastasis, and recurrence.